Blastocystis is an enteric Straminopile in tropical, subtropical and developing countries. Metronidazole has been a chemotheraputic for blastocystosis. Failures in its regimens were reported and necessitate new studies searching for alternative therapeutic agents. Aim of current study is to investigate potential effects of Atorvastatin (AVA) compared to the conventional chemotherapeutic MTZ in experimentally Blastocystis-infected mice. Anti-Blastocystis efficacy of AVA was evaluated parasitologically, histopathologically and by transmission electron microscopy using MTZ (10 mg/kg) as a control. Therapeutic efficacy of AVA was apparently dose-dependent. Regimens of AVA (20 and 40 mg/kg) proved effective against Blastocystis infections with high reduction in Blastocystis shedding (93.4-97.9%) compared to MTZ (79.3%). The highest reductions (98.1% and 99.4%) were recorded in groups of combination treatments AVA 20-40 mg/kg and MTZ 10 mg/kg. Blastocystis was nearly eradicated by the 20th day post infection. Genotype analysis revealed that genotype I was most susceptible, genotype III was less. Histopathologic and ultrastructural studies revealed apoptotic changes in Blastocystis and significant improvement of intestinal histopathological changes more remarkable in combinational therapy groups. Thus, the present study offers AVA as a potential candidate for Blastocystis therapy combined with MTZ.
Citations
Citations to this article as recorded by
Assessment of Lactobacillus acidophilus (L. acidophilus) therapeutic and prophylactic role in rats experimentally infected with Blastocystis subtype 3 (ST3) Sara Fathy Hamed Alkady, Heba Mohamed Awad El Naggar, Hala Sobhy Thabet, Hoda S. El-Sayed, Mona Magdy, Iman Ahmed Fahmy, Hanan Mahmoud Abou-Seri Parasitology Research.2025;[Epub] CrossRef
The Role of Blastocystis spp. in the Etiology of Gastrointestinal and Autoimmune Diseases Oliwia Pawelec-Pęciak, Natalia Łanocha-Arendarczyk, Konrad Grzeszczak, Danuta Kosik-Bogacka Pathogens.2025; 14(4): 313. CrossRef
Assessment of the Therapeutic Role of Allium tuncelianum Extract in Rats Infected with Blastocystis Subtype 3 Mehmet Aykur, Nazan Gökşen Tosun, Aykut Özgür Acta Parasitologica.2025;[Epub] CrossRef
A novel therapeutic potential of the anti-hiv ritonavir against Blastocystis hominis: a dual approach in vitro and in vivo Doaa A. Balaha, Sirria M. Elmarhoumy, Nabila A. Yassen, Dina M. Abou Rayia, Hend S. Abo Safia, Mona M. Tolba Journal of Parasitic Diseases.2025;[Epub] CrossRef
A Systematic Review about the Efficacy of Antiparasitic Agents in the Treatment of Blastocystis Species Özlem Ulusan Bağcı, Gülay Aral Akarsu Acta Parasitologica.2025;[Epub] CrossRef
Impact of atorvastatin and mesenchymal stem cells combined with ivermectin on murine trichinellosis Zeinab R. Hassan, Samar El-Sayed, Kareman M. Zekry, Samah Gouda Ahmed, Asmaa Hassan Abd-Elhamid, Doaa E. A. Salama, Azza Kamal Taha, Nihal A. Mahmoud, Shaymaa Fathy Mohammed, Mona M. Amin, Rasha Elsayed Mohamed, Ayat M. S. Eraque, Shimaa A. Mohamed, Ranya Parasitology Research.2024;[Epub] CrossRef
Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications Marios Spanakis, Danny Alon-Ellenbogen, Petros Ioannou, Nikolaos Spernovasilis Pharmacy.2023; 11(4): 130. CrossRef
Anti-Cryptosporidium efficacy of Citrus sinensis peel extract: Histopathological and ultrastructural experimental study Wegdan M. Abd El Wahab, Raafat M. Shaapan, El-Moataz Bellah El-Naggar, Marwa M. Ahmed, Asmaa I. Owis, Mona I. Ali Experimental Parasitology.2022; 243: 108412. CrossRef
Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens Rachel E. Ham, Lesly A. Temesvari, Laura J. Knoll PLOS Pathogens.2020; 16(12): e1009081. CrossRef
Prenylquinones in Human Parasitic Protozoa: Biosynthesis, Physiological Functions, and Potential as Chemotherapeutic Targets Ignasi Verdaguer, Camila Zafra, Marcell Crispim, Rodrigo Sussmann, Emília Kimura, Alejandro Katzin Molecules.2019; 24(20): 3721. CrossRef
To evaluate the efficacy of ronidazole for treatment of Tritrichomonas foetus infection, 6 Tritrichomonas-free kittens were experimentally infected with a Korean isolate of T. foetus. The experimental infection was confirmed by direct microscopy, culture, and single-tube nested PCR, and all cats demonstrated trophozoites of T. foetus by day 20 post-infection in the feces. From day 30 after the experimentally induced infection, 3 cats were treated with ronidazole (50 mg/kg twice a day for 14 days) and 3 other cats received placebo. Feces from each cat were tested for the presence of T. foetus by direct smear and culture of rectal swab samples using modified Diamond's medium once a week for 4 weeks. To confirm the culture results, the presence of T. foetus rRNA gene was determined by single-tube nested PCR assay. All 3 cats in the treatment group receiving ronidazole showed negative results for T. foetus infection during 2 weeks of treatment and 4 weeks follow-up by all detection methods used in this study. In contrast, rectal swab samples from cats in the control group were positive for T. foetus continuously throughout the study. The present study indicates that ronidazole is also effective to treat cats infected experimentally with a Korean isolate of T. foetus at a dose of 50 mg/kg twice a day for 14 days.
Citations
Citations to this article as recorded by
Metabarcoding of pathogenic parasites based on copro-DNA analysis of wild animals in South Korea Jun Ho Choi, Soo Lim Kim, Dong Kyun Yoo, Myung-hee Yi, Singeun Oh, Myungjun Kim, Sohyeon Yun, Tai-Soon Yong, Seongjun Choe, Jong Koo Lee, Ju Yeong Kim Heliyon.2024; 10(9): e30059. CrossRef
Efficacy of guar gum-based ronidazole capsules as a treatment for Tritrichomonas foetus infection in cats Aurélien Grellet, Seyf Eddine Makhlouf, Loic Desquilbet, Fani Hovhannessian, Cassandre Boogaerts, Vanessa Dore, Myriam Anthony, Bernadette Espana, Caroline Prouillac, Plamen Kirilov, Bruno Polack, Sébastien Perrot Journal of Feline Medicine and Surgery.2017; 19(2): 177. CrossRef
The conundrum of feline trichomonosis: the more we learn the ‘trickier’ it gets Jody L Gookin, Katherine Hanrahan, Michael G Levy Journal of Feline Medicine and Surgery.2017; 19(3): 261. CrossRef
First
Prev
